1
00:00:02,520 --> 00:00:08,800
Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The.

2
00:00:08,880 --> 00:00:13,160
Speaker 2: Stock Movers podcast, your roundup of companies making moves in

3
00:00:13,200 --> 00:00:16,520
Speaker 2: the stock market, harnessing the power of Bloomberg Data.

4
00:00:16,680 --> 00:00:18,360
Speaker 1: Well, let's take a look at some stocks on the

5
00:00:18,400 --> 00:00:21,920
Speaker 1: move today in Europe. I'm Valerie Title with Caroline Hepger,

6
00:00:22,000 --> 00:00:25,599
Speaker 1: when we're joined by Bloomberg's equities reporter Chloe Melay. Chloe.

7
00:00:25,680 --> 00:00:28,560
Speaker 1: Let's start here in the UK with AstraZeneca posting some

8
00:00:28,600 --> 00:00:29,360
Speaker 1: strong earnings.

9
00:00:29,520 --> 00:00:32,839
Speaker 3: Yeah, absolutely good, quite a strong second quarter set of

10
00:00:32,840 --> 00:00:35,680
Speaker 3: results this morning. So we've got better than expected sales

11
00:00:35,720 --> 00:00:38,640
Speaker 3: and rising profit in the second quarter. That's you to

12
00:00:38,720 --> 00:00:41,000
Speaker 3: kind of two main things. So first of all, a

13
00:00:41,040 --> 00:00:43,400
Speaker 3: real focus on cancer medicines, so that's the bet that

14
00:00:43,479 --> 00:00:46,640
Speaker 3: the CEO, Pascal Saria, has made and it's really paying off.

15
00:00:46,800 --> 00:00:49,440
Speaker 3: And then also a really strong focus on the US.

16
00:00:49,479 --> 00:00:52,800
Speaker 3: So you'll remember that very recently AstraZeneca announced a plan

17
00:00:52,880 --> 00:00:55,800
Speaker 3: to invest as much as fifty billion dollars in the

18
00:00:55,920 --> 00:00:59,840
Speaker 3: US by twenty thirty for manufacturing and for recent and development.

19
00:01:00,800 --> 00:01:03,160
Speaker 3: So this focus on the US and this focus on

20
00:01:03,160 --> 00:01:06,840
Speaker 3: oncology is really working well for astra Zeneca. If we

21
00:01:06,880 --> 00:01:09,920
Speaker 3: look at kind of catalysts going forward. A lot actually

22
00:01:10,000 --> 00:01:13,679
Speaker 3: hinges on a potential blockbuster breast cancer drug called Dataway,

23
00:01:14,280 --> 00:01:16,600
Speaker 3: but Ashra said that it was pushing back the results

24
00:01:16,680 --> 00:01:19,760
Speaker 3: of that study on that drug to next year rather

25
00:01:19,840 --> 00:01:21,880
Speaker 3: than this year, so it was supposed to come out

26
00:01:21,880 --> 00:01:25,000
Speaker 3: this year. So investors will be really keeping a close

27
00:01:25,040 --> 00:01:26,760
Speaker 3: eye on this and that will be key for the

28
00:01:26,800 --> 00:01:30,600
Speaker 3: share performance because Ashrazeneka, despite those strong results, has been

29
00:01:30,680 --> 00:01:34,760
Speaker 3: underperforming some of its spears like nevaratists in Switzerland for example,

30
00:01:35,200 --> 00:01:37,000
Speaker 3: So we'll be keeping an eye on that going forward

31
00:01:37,000 --> 00:01:37,880
Speaker 3: as well. Yeah.

32
00:01:37,920 --> 00:01:41,520
Speaker 4: Absolutely, I mean asked a fifty billion dollar manufacturing investment

33
00:01:41,560 --> 00:01:45,319
Speaker 4: in the US is significant. UK lost that on some

34
00:01:45,480 --> 00:01:48,080
Speaker 4: investment too. That was a few months ago, but you

35
00:01:48,120 --> 00:01:52,480
Speaker 4: know that's very significant. Phillips this morning sawing why.

36
00:01:52,640 --> 00:01:55,880
Speaker 3: Yeah, so Phillips said, it's really interesting reversal from Phillips.

37
00:01:55,920 --> 00:01:58,840
Speaker 3: So it actually raised its profitability outlook and there's just

38
00:01:59,000 --> 00:02:01,960
Speaker 3: a couple of months after actually cutting it. So it

39
00:02:02,080 --> 00:02:05,200
Speaker 3: said in it kind of an outlook in May as

40
00:02:05,400 --> 00:02:07,760
Speaker 3: was due to the tariff impact, to the impact of

41
00:02:07,760 --> 00:02:10,239
Speaker 3: the trade war, but then today it said that the

42
00:02:10,320 --> 00:02:12,960
Speaker 3: impact of that trade war was actually not as bad

43
00:02:13,040 --> 00:02:15,800
Speaker 3: as it originally feared. So it raised it again. So

44
00:02:15,840 --> 00:02:18,079
Speaker 3: it's kind of a quick turnaround if you think about

45
00:02:18,120 --> 00:02:20,639
Speaker 3: the fact that it's over the course of just two

46
00:02:20,680 --> 00:02:23,840
Speaker 3: months that it kind of digested that impact and raised

47
00:02:23,840 --> 00:02:27,519
Speaker 3: that outlook again. At the time in May had estimated

48
00:02:27,720 --> 00:02:29,960
Speaker 3: a hit of as much as three hundred million euros.

49
00:02:30,400 --> 00:02:33,480
Speaker 3: Now it sees an impact of just two hundred million,

50
00:02:33,560 --> 00:02:36,160
Speaker 3: so it's quite quite a bit a significant drop there.

51
00:02:37,280 --> 00:02:39,560
Speaker 3: This really provided kind of a relief to the Shes

52
00:02:39,560 --> 00:02:41,840
Speaker 3: They have been struggled. They have been struggling over the

53
00:02:41,919 --> 00:02:44,639
Speaker 3: last year or so. That was due to the trade war,

54
00:02:44,639 --> 00:02:47,240
Speaker 3: which obviously the worries there are lifting a little bit,

55
00:02:47,320 --> 00:02:49,840
Speaker 3: especially with the new trade deal, but then also weakness

56
00:02:50,280 --> 00:02:52,320
Speaker 3: in China and that is still continuing however.

57
00:02:52,520 --> 00:02:54,919
Speaker 1: Yeah so shares a Phillips jumping more than ten percent,

58
00:02:55,000 --> 00:02:56,959
Speaker 1: one of the best performing stocks in Europe this morning,

59
00:02:57,320 --> 00:03:00,480
Speaker 1: very quickly on a Stilantis. A bit of a different

60
00:03:00,480 --> 00:03:02,160
Speaker 1: picture there when it comes to their terraforming.

61
00:03:02,400 --> 00:03:06,120
Speaker 3: Yeah, absolutely so. They are estimating a one point two

62
00:03:06,200 --> 00:03:09,320
Speaker 3: billion euro hit from tariff's in the second half of

63
00:03:09,360 --> 00:03:13,079
Speaker 3: the year. They also lowered the guidance for operating margint

64
00:03:13,120 --> 00:03:15,200
Speaker 3: they see low single digit They had seen mid single

65
00:03:15,200 --> 00:03:18,359
Speaker 3: digit as obviously of the back of the pre release

66
00:03:18,440 --> 00:03:20,440
Speaker 3: that they had last week where they announced that two

67
00:03:20,480 --> 00:03:23,800
Speaker 3: point three billion euro loss and this falsett of earnings

68
00:03:23,840 --> 00:03:27,000
Speaker 3: really did not reassure investors, and we are expecting more

69
00:03:27,040 --> 00:03:30,040
Speaker 3: and more of that tariffon certainty weighing on stillantis and

70
00:03:30,080 --> 00:03:33,800
Speaker 3: on the wider maybe car making sector as well, despite

71
00:03:33,800 --> 00:03:34,359
Speaker 3: that trend deal.

72
00:03:35,600 --> 00:03:39,720
Speaker 2: The Stock Movers podcast from Bloomberg Radio. Check back with

73
00:03:39,840 --> 00:03:42,600
Speaker 2: us throughout the day for the latest roundup of companies

74
00:03:42,640 --> 00:03:45,680
Speaker 2: making news on Wall Street and for the latest market

75
00:03:45,720 --> 00:03:50,080
Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,

76
00:03:50,120 --> 00:03:53,360
Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with

77
00:03:53,440 --> 00:03:54,920
Speaker 2: the Bloomberg Business app.